A carregar...
Bevacizumab in Treatment of High-Risk Ovarian Cancer—A Cost-Effectiveness Analysis
OBJECTIVE. The objective of this study was to evaluate a cost-effectiveness strategy of bevacizumab in a subset of high-risk advanced ovarian cancer patients with survival benefit. METHODS. A subset analysis of the International Collaboration on Ovarian Neoplasms 7 trial showed that additions of bev...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4012959/ https://ncbi.nlm.nih.gov/pubmed/24721817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0322 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|